title: Optimum doses of irinotecan.
authors.forename: C
authors.initials: C
authors.lastname: Erlichman
authors.forename: R M
authors.initials: RM
authors.lastname: Goldberg
authors.forename: H C
authors.initials: HC
authors.lastname: Pitot
authors.forename: M J
authors.initials: MJ
authors.lastname: O'Connell
mesh_terms: D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D000077146:Irinotecan; D059004:Topoisomerase I Inhibitors
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D002166:Camptothecin